Pharmaceutical Company Drug Assistance Programs - HealthyPlace
Links shared publicly online about this topic.
- 374total visits
Pharmaceutical Company Drug Assistance Programs - HealthyPlace
View full resource at healthyplace.com
Tags: Drug, Pharma, Patient Assistance
Most Recently Shared on April 11, 2011 at 6:27 pm By:
Patient Assistance Programs Listed by Psychiatric Medication http://bit.ly/hUQJqm #PAP #medications #mentalhealth #mhsm #pharma
Pharmaceutical sales training – a new point of view | Sales Training Connection
salestrainingconnection.com — “Pharmaceutical companies are reducing the size of their sales force and introducing digital tools – where physicians can ask questions about drugs, order free samples, and find out which insurers cover certain treatments by using, for example, an iPad app. This will require a new and different type of sales training for some new and different players. Some companies have acknowledged this reality and modified their sales training programs to include everyone in sales training who has interaction” View full resource at salestrainingconnection.com
Most Recently Shared on April 10, 2012 at 3:52 pm By:
Dan Baxter Pharma and Health Social Media
Pharmaceutical sales training – a new point of view | Sales Training Connection http://t.co/juoym1NS <Love this! #hcsmeu #socpharm
ProStrakan announces FDA approval for Transmucosal Immediate Release Fentanyl REMS Access program
news-medical.net — “ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that the U.S. Food and Drug Administration has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS Access program.” View full resource at news-medical.net
Most Recently Shared on December 31, 2011 at 9:46 am By:
Asthma News: ProStrakan announces FDA approval for Transmucosal Immediate Release Fentanyl REMS Access program: ... http://t.co/nPPSI5Gr
RADARS > Home2
radars.org — “The RADARS System measures rates of abuse, misuse and diversion throughout the United States, contributing to the understanding of trends and aiding the development of effective interventions. These data assist pharmaceutical companies in fulfillment of their regulatory obligations” View full resource at radars.org
Most Recently Shared on November 5, 2011 at 12:21 am By:
Christian Sinclair Physician, Doctor, Internist, and Pain Medicine Physician
Any #hpm docs ever heard of Purdue sponsored RADARS http://t.co/b1uyEm5S ? Site w/ data abt prescription drug abuse
Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility
news-medical.net — “PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by leading drug discovery company, Astex Pharmaceuticals to seek a buyer for an established full service CMC & Formulation Facility in Pleasanton, California. The engagement will utilise PharmaVentures' asset divestment expertise in the life sciences sector.” View full resource at news-medical.net
Most Recently Shared on September 9, 2011 at 10:28 am By:
Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility: PharmaVentures Limited, exper... http://t.co/jm36VlW
HIV Drug Discounts Shut Down in Middle-Income Countries | Doctors Without Borders
doctorswithoutborders.org — “Several pharmaceutical companies have abandoned HIV drug discount programs in middle-income countries, according to an HIV drug price report released by MSF.” View full resource at doctorswithoutborders.org
Most Recently Shared on July 19, 2011 at 8:02 pm By:
Doctors w/o Borders Health Organization
HIV Drug Discounts Shut Down in Middle-Income Countries http://bit.ly/pVbqeH #IAC2011 #AIDS #HIV
Amylin Pharmaceuticals To Present Promising New Data On The Company's Diabetes Programs At ADA 2011
medicalnewstoday.com — “Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA® (exenatide) injection and SYMLIN® (pramlintide a” View full resource at medicalnewstoday.com
Most Recently Shared on June 21, 2011 at 7:05 am By:
MNT Pharma News Health News and Pharma
Amylin Pharmaceuticals To Present Promising New Data On The Company's Diabetes Programs At ADA 2011 http://mnt.to/3XqW
Viral Genetics Updates HIV/AIDS And Drug Resistant Cancer Research Programs
medicalnewstoday.com — “Viral Genetics, Inc. (Pinksheets: VRAL) continues to make the transition to a clinical-stage company. The Company's two lead pharmaceutical programs -- APi1177 for HIV/AIDS, and various Metabolic” View full resource at medicalnewstoday.com
Most Recently Shared on June 16, 2011 at 7:05 am By:
Viral Genetics Updates HIV/AIDS And Drug Resistant Cancer Research Programs http://mnt.to/3XfH #hivaids
Spectrum board authorizes $25 million stock repurchase program
news-medical.net — “Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that its Board of Directors has authorized the purchase of up to $25 million of its common stock through the end of 2012.” View full resource at news-medical.net
Most Recently Shared on June 15, 2011 at 1:50 pm By:
Spectrum board authorizes $25 million stock repurchase program: Spectrum Pharmaceuticals, Inc., a biotechnology ... http://bit.ly/lB1e1x
FDA accepts EffRx NDA for EX101 to treat osteoporosis
news-medical.net — “EffRx Pharmaceuticals SA, an Epalinges/Lausanne, Switzerland based drug delivery company announces that the New Drug Application for the company's lead development program EX101 has been accepted for filing by the US Food and Drug Administration.” View full resource at news-medical.net
Most Recently Shared on May 12, 2011 at 8:12 am By:
Osteoporosis News: FDA accepts EffRx NDA for EX101 to treat osteoporosis: EffRx Pharmaceuticals SA, an Epalinges... http://bit.ly/iTifuL
NDA Accepted for EX101 for Osteoporosis - ONA
oncologynurseadvisor.com — “EffRx Pharmaceuticals announced the FDA has accepted its new drug application for the company's lead development program EX101.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 11, 2011 at 5:52 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
NDA Accepted for EX101 for Osteoporosis http://goo.gl/fb/YV7ZO
NDA Accepted for EX101 for Osteoporosis - MPR
empr.com — “EffRx Pharmaceuticals announced the FDA has accepted its new drug application for the company's lead development program EX101.” View full resource at empr.com
Most Recently Shared on May 11, 2011 at 5:42 pm By:
MPR News: NDA Accepted for EX101 for Osteoporosis: EffRx Pharmaceuticals announced the FDA has accepted its new ... http://bit.ly/mxE2Ir
The Rise Of The Pharmaceutical Un-Sales Force - On the Docket - Inside the courtroom - Forbes
blogs.forbes.com — “In a variation on the old saying --if you can--™t beat --'em, join --'em,-- a number of states have initiated programs where purportedly independent clinicians, pharmacists and other medical personnel pay visits to physicians as a way of countering the information delivered to health care providers by drug company sales [...]” View full resource at blogs.forbes.com
Most Recently Shared on April 26, 2011 at 3:23 pm By:
Jack Friday - PharmaGossip Health Blog
RT @UFCWRx: The Rise Of The Pharmaceutical Un-Sales Force - Medical "Truth Squads" visiting MD's to counter “detailers†http://goo.gl/SUPy5
Allergy Therapeutics Shares Rise As FDA Agrees To Lift Clinical Hold On Products
rttnews.com — “Specialty pharmaceutical company Allergy Therapeutics Plc (AGY.L) Tuesday said the US Food and Drug Administration will lift its clinical hold on Investigational New Drug applications for three of the company's Pollinex Quattro products, once the protocols have been agreed.” View full resource at rttnews.com
Most Recently Shared on April 26, 2011 at 10:15 am By:
John Carroll Health Communicator
FDA will lift clinical hold on Allergy Therapeutics vaccine program. Shares get a bump. http://bit.ly/gTf2Ry
AHF praises CA Treasurer for urging AIDS drug companies to reduce medication costs
news-medical.net — “Today AIDS Healthcare Foundation praised California State Treasurer Bill Lockyer for sending letters to the CEOs of eight AIDS drug companies--"Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead Sciences, Merck & Co., Tibotec Therapeutics and ViiV Healthcare--"urging them to reduce the price of their HIV/AIDS medications for California and its AIDS Drug Assistance Program.” View full resource at news-medical.net
Most Recently Shared on April 11, 2011 at 12:34 pm By:
HIV/AIDS News: AHF praises CA Treasurer for urging AIDS drug companies to reduce medication costs: Today AIDS He... http://bit.ly/eSZ4V4
PhRMA Statement Regarding FDA Oversight of Promotion Online | PhRMA
phrma.org — “Washington, D.C. (March 31, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Assistant General Counsel Jeffrey K. Francer issued the following statement today on the FDA’s anticipated social media guidance:"PhRMA has engaged the Food and Drug Administration (FDA) in public discussion of how our member companies can appropriately communicate with healthcare providers and patients online, using the same tools as the FDA and the White House, including Twitter, F” View full resource at phrma.org
Most Recently Shared on April 1, 2011 at 3:06 pm By:
Jon J. Tripp Health Organization
Don't fall for April fools jokes. @PhRMA 's REAL statement on FDA's social media: http://bit.ly/g1z91d @Farmacopea @JaredS81 @wiltonbound
Advertisement
